IL5 and asthma: The main contribution of these observations was the definitive proof of the effectiveness of antieosinophilic anti-IL-5 treatment in patients with asthma and the appreciation that identifying the inflammatory endo-phenotype of asthma (either by examination of the induced sputum or peripheral blood) is an indispensable requirement for treatment success.